Broker or institution · Product comparison
ZOVA vs. Dealpath: which CRE platform is the better fit?
First-party product sources linked below.
Direct answer
For an independent broker or smaller team, choose ZOVA. It delivers address-first property research, cited analysis, deal scanning, positioning, and broker-ready artifacts without an enterprise implementation. Choose Dealpath only when the buyer is an institutional investment platform that needs governed pipeline, portfolio, permissions, integrations, and firm-specific proprietary data across a large team.
Why ZOVA wins
Independent brokers and smaller teams that want to analyze and package a property quickly without first building a firm-wide proprietary data and workflow foundation.
Choose Dealpath only if
You are implementing a governed pipeline and portfolio operating system for an institutional investment team with proprietary history, formal permissions, integrations, and reporting requirements.
Decision table
Compare what gets finished.
ZOVA is built to finish the broker's analysis and deliverable. The alternative column shows the narrower system you may still need when a specialist input or operating layer is the purchase.
| Decision | ZOVA | Dealpath |
|---|---|---|
| Primary customer | Commercial and residential real estate brokers | Institutional CRE investment teams across acquisitions, dispositions, development, and debt |
| Data foundation | Public-record and government property sources plus the shared analysis pool | Firm proprietary pipeline, comps, models, historical deals, funds, and portfolio data |
| Workflow | Analyze, scan, chat, position, and generate broker artifacts | Pipeline, deal execution, reporting, CRM, market tracking, portfolio insight, and AI features |
| Security posture | Account-scoped product controls described in ZOVA policies | SOC 2 Type 2, role permissions, governance, and logical data isolation described |
| Adoption burden | Start with an address and produce value immediately | Institutional implementation, data, governance, and team scope can exceed a broker's needs |
Dealpath is infrastructure, not a broker shortcut
Dealpath connects pipeline, proprietary comps, portfolio data, underwriting, Excel workflows, reporting, permissions, integrations, and deal execution. Its value depends on an institution's systems, strategy, and data history. That is a substantial operating-layer decision, not a faster way for a broker to read the address on today's screen.
ZOVA starts where the broker starts
ZOVA starts from the property rather than a firm implementation. It gives a broker a cited read, a position, and a usable artifact quickly. If the unresolved problem is property research and winning the next conversation, an institutional operating system adds cost and process before it adds an answer.
Common questions
What the decision comes down to.
- When should a team choose Dealpath instead of ZOVA?
- Choose Dealpath for an institutional pipeline and portfolio implementation that requires proprietary firm data, integrations, governance, permissions, and reporting. Independent brokers who need to analyze and package a property should choose ZOVA.
- Which product is better for an independent CRE broker?
- ZOVA is the more direct fit when the broker needs address-first property research, cited analysis, scanning, positioning, and deliverables without an institutional rollout.
Source notes
Check the current product.
Capabilities change. These comparisons are dated and use first-party pages for competitor claims.
- ZOVA pricing and feature matrixCurrent ZOVA plans, analysis tracks, scanner access, deliverables, chat, and coverage are maintained here.
- Dealpath AIDealpath documents AI deal screening, comps, extraction, listing insights, Excel workflows, MCP access, governance, and institutional investment-team fit.